TAE Life Sciences
Linnette Capo has extensive experience in the field of biological sciences, currently serving as a Scientist at TAE Life Sciences since December 2019, after previously holding the position of Associate Scientist in Translational Research. Prior to TAE Life Sciences, Linnette worked at Xencor as an Associate Scientist from September 2018 to December 2019. A significant portion of Linnette's career was spent at Agensys Inc./Astellas Pharma U.S., holding various roles within the Pharmacology Department from 2002 to 2018, culminating in the position of Senior Principal Associate. Early career experience includes roles at the Kenneth S. Warren Institute and Cadus Pharmaceutical Corp., alongside research technician experience at the University of Puerto Rico. Linnette holds both an MS and a BS in Biology from the Universidad de Puerto Rico, earned between 1987 and 1996.
This person is not in any offices
TAE Life Sciences
3 followers
New medical technology enabling convenient clinical access to Boron Neutron Capture Therapy (BNCT), a promising, previously inaccessible cancer treatment.